Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP666308.RAZ40NuUkS9aenhGy6TNRbbxKsCzvFGs9DzPiaQQ3lUCE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP666308.RAZ40NuUkS9aenhGy6TNRbbxKsCzvFGs9DzPiaQQ3lUCE130_assertion type Assertion NP666308.RAZ40NuUkS9aenhGy6TNRbbxKsCzvFGs9DzPiaQQ3lUCE130_head.
- NP666308.RAZ40NuUkS9aenhGy6TNRbbxKsCzvFGs9DzPiaQQ3lUCE130_assertion wasGeneratedBy ECO_0000203 NP666308.RAZ40NuUkS9aenhGy6TNRbbxKsCzvFGs9DzPiaQQ3lUCE130_provenance.
- NP666308.RAZ40NuUkS9aenhGy6TNRbbxKsCzvFGs9DzPiaQQ3lUCE130_assertion wasDerivedFrom befree-20140225 NP666308.RAZ40NuUkS9aenhGy6TNRbbxKsCzvFGs9DzPiaQQ3lUCE130_provenance.
- NP666308.RAZ40NuUkS9aenhGy6TNRbbxKsCzvFGs9DzPiaQQ3lUCE130_assertion SIO_000772 19013896 NP666308.RAZ40NuUkS9aenhGy6TNRbbxKsCzvFGs9DzPiaQQ3lUCE130_provenance.
- NP666308.RAZ40NuUkS9aenhGy6TNRbbxKsCzvFGs9DzPiaQQ3lUCE130_assertion evidence source_evidence_literature NP666308.RAZ40NuUkS9aenhGy6TNRbbxKsCzvFGs9DzPiaQQ3lUCE130_provenance.
- NP666308.RAZ40NuUkS9aenhGy6TNRbbxKsCzvFGs9DzPiaQQ3lUCE130_assertion description "[Inhibitors of the tyrosine kinase receptors, such as IGF-1R, c-kit, PDGFR, VEGFR, or the mTOR signaling pathway, proteasome, angiogenesis, and stress response proteins are under clinical evaluation against sarcomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP666308.RAZ40NuUkS9aenhGy6TNRbbxKsCzvFGs9DzPiaQQ3lUCE130_provenance.